All-Oral Treatment With Daclatasvir (DCV) Plus Sofosbuvir (SOF) Plus Ribavirin (RBV) for 12 or 16 Weeks in HCV Genotype (GT) 3-Infected Patients With Advanced Fibrosis or Cirrhosis: The ALLY-3+Phase 3 Study Conference Proceedings uri icon

Overview

Authors

  • Authorship

    • LEROY V
    • MCPHEE F
    • BHORE R
    • EXPOSITO MJJ
    • DR Alex Thompson
    • ANGUS PW
    • BRONOWICKI J-P
    • DORE G
    • HEZODE C
    • PIANKO S
    • POL S
    • STUART KA
    • TSE E

Published in

  • Hepatology

Time

Date/time value

  • 2015

Additional Document Info

Parent Title

  • HEPATOLOGY

Volume

  • 62

Issue

  • 6

Publisher

  • WB Saunders Co